Dow Jones

38,834.86

0.15%

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
USOTC
Regen Biopharma Inc (PK) (RGBPP)
Regen Biopharma Inc (PK) (RGBPP) News

Regen Biopharma (PK) (RGBPP)

Regen Biopharma Inc (PK)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:RGBPP

1 2 3 4 Next >>

Date	Time	Source	Headline	Symbol	Company
29/05/2024	18:12	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
29/05/2024	18:11	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RGBPP	Regen Biopharma Inc (PK)
23/05/2024	14:32	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
23/05/2024	14:31	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RGBPP	Regen Biopharma Inc (PK)
10/05/2024	20:50	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
10/05/2024	20:49	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RGBPP	Regen Biopharma Inc (PK)
09/02/2024	21:15	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
09/02/2024	21:14	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RGBPP	Regen Biopharma Inc (PK)
19/01/2024	18:29	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
19/01/2024	18:29	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
20/11/2023	14:38	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
20/11/2023	14:37	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	USOTC:RGBPP	Regen Biopharma Inc (PK)
02/10/2023	18:42	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
02/10/2023	05:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	USOTC:RGBPP	Regen Biopharma Inc (PK)
25/09/2023	16:25	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	USOTC:RGBPP	Regen Biopharma Inc (PK)
18/09/2023	21:02	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RGBPP	Regen Biopharma Inc (PK)
25/07/2023	20:39	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
24/07/2023	19:59	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	USOTC:RGBPP	Regen Biopharma Inc (PK)
15/05/2023	15:27	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:RGBPP	Regen Biopharma Inc (PK)
15/05/2023	11:28	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:RGBPP	Regen Biopharma Inc (PK)
13/04/2023	11:29	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:RGBPP	Regen Biopharma Inc (PK)
21/03/2023	17:52	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
07/02/2023	12:14	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
19/01/2023	20:42	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:RGBPP	Regen Biopharma Inc (PK)
21/11/2022	22:12	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
18/11/2022	11:37	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
15/11/2022	20:38	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
14/11/2022	17:06	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
20/09/2022	12:04	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
22/07/2022	19:43	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:RGBPP	Regen Biopharma Inc (PK)